-
1دورية أكاديمية
المؤلفون: Villacampa, G, Tung, N M, Pernas, S, Paré, L, Bueno-Muiño, C, Echavarría, I, López-Tarruella, S, Roche-Molina, M, Del Monte-Millán, M, Marín-Aguilera, M, Brasó-Maristany, F, Waks, A G, Pascual, T, Martínez-Sáez, O, Vivancos, A, Conte, P F, Guarneri, V, Vittoria Dieci, M, Griguolo, G, Cortés, J, Llombart-Cussac, A, Muñoz, M, Vidal, M, Adamo, B, Wolff, A C, DeMichele, A, Villagrasa, P, Parker, J S, Perou, C M, Fernandez-Martinez, A, Carey, L A, Mittendorf, E A, Martín, M, Prat, A, Tolaney, S M
المساهمون: Villacampa, G, Tung, N M, Pernas, S, Paré, L, Bueno-Muiño, C, Echavarría, I, López-Tarruella, S, Roche-Molina, M, Del Monte-Millán, M, Marín-Aguilera, M, Brasó-Maristany, F, Waks, A G, Pascual, T, Martínez-Sáez, O, Vivancos, A, Conte, P F, Guarneri, V, Vittoria Dieci, M, Griguolo, G, Cortés, J, Llombart-Cussac, A, Muñoz, M, Vidal, M, Adamo, B, Wolff, A C, Demichele, A, Villagrasa, P, Parker, J S, Perou, C M, Fernandez-Martinez, A, Carey, L A, Mittendorf, E A, Martín, M, Prat, A, Tolaney, S M
مصطلحات موضوعية: HER2, HER2DX, breast cancer, neoadjuvant, pathological complete response, pertuzumab
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37302750; info:eu-repo/semantics/altIdentifier/wos/WOS:001065301400001; numberofpages:13; journal:ANNALS OF ONCOLOGY; https://hdl.handle.net/11577/3491164Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85165687043; https://www.sciencedirect.com/science/article/pii/S0923753423007214?via=ihubTest
الإتاحة: https://doi.org/10.1016/j.annonc.2023.05.012Test
https://hdl.handle.net/11577/3491164Test
https://www.sciencedirect.com/science/article/pii/S0923753423007214?via=ihubTest -
2دورية أكاديمية
المؤلفون: Prat, A, Lluch, A, Albanell, J, Barry, W T, Fan, C, Chacón, J I, Parker, J S, Calvo, L, Plazaola, A, Arcusa, A, Seguí-Palmer, M A, Burgues, O, Ribelles, N, Rodriguez-Lescure, A, Guerrero, A, Ruiz-Borrego, M, Munarriz, B, López, J A, Adamo, B, Cheang, M C U, Li, Y, Hu, Z, Gulley, M L, Vidal, M J, Pitcher, B N, Liu, M C, Citron, M L, Ellis, M J, Mardis, E, Vickery, T, Hudis, C A, Winer, E P, Carey, L A, Caballero, R, Carrasco, E, Martín, M, Perou, C M, Alba, E
المساهمون: Prat,A, Adamo,B, Vidal,M.J Translational Genomics Group, Vall D'Hebron Institute of Oncology (VHIO) Barcelona, Spain. Prat,A Department of Medicine, Universitat Autònoma de Barcelona, Spain. Lluch,A, Burgues,O Department of Medical Oncology, Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. Albanell,J Department of Medical Oncology, Hospital Del Mar, IMIM, Barcelona, Spain. Albanell,J Department of Medical Oncology, Universitat Pompeu Fabra (UPF), Barcelona, Spain. Barry,W.T Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, United States. Fan,C, Parker,J.S, Cheang,M.C.U, Li,Y, Hu,Z, Gulley,M.L, Carey,L.A, Perou,C.M Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States. Chacón,J.I Department of Medical Oncology, Hospital Virgen de la Salud, Toledo, Spain. Parker,J.S, Perou,C.M Department of Genetics, University of North Carolina, Chapel Hill, NC, United States. Calvo,L Department of Medical Oncology, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain. Plazaola,A Department of Medical Oncology, Onkologikoa, San-Sebastián, Spain. Arcusa,A Department of Medical Oncology, Consorci Sanitari de Terrassa, Barcelona, Spain. Seguí-Palmer,M.A Department of Medical Oncology, Corporació Sanitària Parc Taulí, Sabadell, Spain. Ribelles,N, Alba,E Department of Medical Oncology, Department of Pathology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. Rodríguez-Lescure,A Department of Medical Oncology, Hospital General de Elche, Alicante, Spain. Guerrero,A Department of Medical Oncology, Instituto Valenciano de Oncología (IVO), Valencia, Spain. Ruiz-Borrego,M Department of Medical Oncology, Hospital Universitario Virgen Del Rocío, Sevilla, Spain. Munarriz,B Department of Medical Oncology, Hospital Universitario la Fe, Valencia, Spain. López,J.A Department of Medical Oncology, Hospital San Camilo, Madrid, Spain. Pitcher,B.N Alliance Statistical and Data Center, Duke University, Durham, NC, United States. Liu,M.C Department of Oncology, Mayo Clinic, Rochester, MN, United States. Citron,M.L ProHEALTH Care Assoc., LLP, Lake Success, NY, United States. Ellis,M.J, Mardis,E, Vickery,T Department of Oncology, Washington University St. Louis, MO, United States. Hudis,C.A Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States. Winer,E.P Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States. Caballero,R, Carrasco,E, Martín,M GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain. Martín,M Department of Medical Oncology, Instituto de Investigación Sanitaria, Hospital Universitario Gregorio Marañón, Madrid, Spain. Perou,C.M Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, United States., This work was supported by funds from the NCI Breast SPORE program Grant No. P50-CA58223-09A1 (CMP), by RO1-CA138255 (CMP), by the Breast Cancer Research Foundation (CMP and MJE), National Cancer Institute (NCI) Strategic Partnering to Evaluate Cancer Signatures Grant No. U01 CA114722-01 (MJE), by the Sociedad Española de Oncología Médica (AP), by FEDER (RETICC-RD12/0036/0051, RD12/0036/0042, RD12/0036/0076, RD12/0036/0070), by Instituto de Salud Carlos III—PI13/01718 (AP), by Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (AP) and by the Alliance Statistics and Data Center (U10-CA33601).
مصطلحات موضوعية: Breast Cancer, Genomics, Subtypes, Intrisic, Basal Like, Chemotherapy, Neoadjuvant, Resultado del tratamiento, Neoplasias de la mama triple negativas, Antineoplásicos, Análisis de supervivencia, Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies, Medical Subject Headings::Check Tags::Female, Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans, Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged, Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Survival Analysis, Medical Subject Headings::Health Care::Health Services Administration::Quality of Health Care::Outcome and Process Assessment (Health Care)::Outcome Assessment (Health Care)::Treatment Outcome, Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms, Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents
وصف الملف: application/pdf
العلاقة: http://www.nature.com/bjc/journal/v111/n8/full/bjc2014444a.html#absTest; Prat A, Lluch A, Albanell J, Barry WT, Fan C, Chacón JI, et al. Predicting response and survival in chemotherapy-treated triple-negative breast cancer. Br. J. Cancer. 2014; 111(8):1532-41; http://hdl.handle.net/10668/2031Test; PMC4200088
-
3دورية أكاديمية
المؤلفون: Prat, A., Lluch, A., Albanell, J., Barry, W. T., Fan, C., Chacón, J. I., Parker, J. S., Calvo, L., Plazaola, A., Arcusa, A., Seguí-Palmer, M. A., Burgues, O., Ribelles, N., Rodriguez-Lescure, A., Guerrero, A., Ruiz-Borrego, M., Munarriz, B., López, J. A., Adamo, B., Cheang, M. C.U., Li, Y., Hu, Z., Gulley, M. L., Vidal, M. J., Pitcher, B. N., Liu, M. C., Citron, M. L., Ellis, M. J., Mardis, E., Vickery, T., Hudis, C. A., Winer, E. P., Carey, L. A., Caballero, R., Carrasco, E., Martín, M., Perou, C. M., Alba, E.
المصدر: British Journal of Cancer, 111(8)
مصطلحات موضوعية: Cancérologie, Soustype, Survival, Genomics, neoadjuvant, Chemotherapy, Malignant tumor, intrinsic, Subtype, Cancer, Neoadjuvant treatment, Breast disease, Génome, Traitement néoadjuvant, Treatment, Cancerology, basal like, Genome, Génomique, Cancer du sein, subtypes, Triple negative breast cancer, Breast cancer, Mammary gland diseases
العلاقة: https://doi.org/10.17615/dftp-9h32Test; https://cdr.lib.unc.edu/downloads/xk81js270?file=thumbnailTest; https://cdr.lib.unc.edu/downloads/xk81js270Test
الإتاحة: https://doi.org/10.17615/dftp-9h32Test
https://cdr.lib.unc.edu/downloads/xk81js270?file=thumbnailTest
https://cdr.lib.unc.edu/downloads/xk81js270Test -
4
المؤلفون: Lourdes Calvo, Brandy Pitcher, Chun-Yang Fan, Álvaro Rodríguez-Lescure, Lisa A. Carey, Blanca Munárriz, William T. Barry, Eric P. Winer, Eva Carrasco, Marc L. Citron, Aleix Prat, Nuria Ribelles, Maggie C.U. Cheang, Elaine R. Mardis, MC Liu, Manuel Ruiz-Borrego, Jose Ignacio Chacon, A. Arcusa, Rafael Caballero, Joan Albanell, E. Alba, Tammi L. Vickery, Matthew J. Ellis, Joel S. Parker, A. Lluch, Clifford A. Hudis, Yufeng Li, Miguel Angel Seguí-Palmer, Ángel L Guerrero, Barbara Adamo, Arrate Plazaola, Margaret L. Gulley, Miguel Martin, Octavio Burgues, José A. López, Maria Vidal, Zhiyuan Hu, Charles M. Perou
المساهمون: Universitat de Barcelona, [Prat,A, Adamo,B, Vidal,M.J] Translational Genomics Group, Vall D'Hebron Institute of Oncology (VHIO) Barcelona, Spain. [Prat,A] Department of Medicine, Universitat Autònoma de Barcelona, Spain. [Lluch,A, Burgues,O] Department of Medical Oncology, Department of Pathology, Hospital Clínico Universitario de Valencia, Spain. [Albanell,J] Department of Medical Oncology, Hospital Del Mar, IMIM, Barcelona, Spain. [Albanell,J] Department of Medical Oncology, Universitat Pompeu Fabra (UPF), Barcelona, Spain. [Barry,W.T] Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, United States. [Fan,C, Parker,J.S, Cheang,M.C.U, Li,Y, Hu,Z, Gulley,M.L, Carey,L.A, Perou,C.M] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States. [Chacón,J.I] Department of Medical Oncology, Hospital Virgen de la Salud, Toledo, Spain. [Parker,J.S, Perou,C.M] Department of Genetics, University of North Carolina, Chapel Hill, NC, United States. [Calvo,L] Department of Medical Oncology, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain. [Plazaola,A] Department of Medical Oncology, Onkologikoa, San-Sebastián, Spain. [Arcusa,A] Department of Medical Oncology, Consorci Sanitari de Terrassa, Barcelona, Spain. [Seguí-Palmer,M.A] Department of Medical Oncology, Corporació Sanitària Parc Taulí, Sabadell, Spain. [Ribelles,N, Alba,E] Department of Medical Oncology, Department of Pathology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Rodríguez-Lescure,A] Department of Medical Oncology, Hospital General de Elche, Alicante, Spain. [Guerrero,A] Department of Medical Oncology, Instituto Valenciano de Oncología (IVO), Valencia, Spain. [Ruiz-Borrego,M] Department of Medical Oncology, Hospital Universitario Virgen Del Rocío, Sevilla, Spain. [Munarriz,B] Department of Medical Oncology, Hospital Universitario la Fe, Valencia, Spain. [López,J.A] Department of Medical Oncology, Hospital San Camilo, Madrid, Spain.[Pitcher,B.N] Alliance Statistical and Data Center, Duke University, Durham, NC, United States. [Liu,M.C] Department of Oncology, Mayo Clinic, Rochester, MN, United States. [Citron,M.L] ProHEALTH Care Assoc., LLP, Lake Success, NY, United States. [Ellis,M.J, Mardis,E, Vickery,T] Department of Oncology, Washington University St. Louis, MO, United States. [Hudis,C.A] Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States. [Winer,E.P] Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States. [Caballero,R, Carrasco,E, Martín,M] GEICAM (Spanish Breast Cancer Research Group), Madrid, Spain. [Martín,M] Department of Medical Oncology, Instituto de Investigación Sanitaria, Hospital Universitario Gregorio Marañón, Madrid, Spain. [Perou,C.M] Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, United States., This work was supported by funds from the NCI Breast SPORE program Grant No. P50-CA58223-09A1 (CMP), by RO1-CA138255 (CMP), by the Breast Cancer Research Foundation (CMP and MJE), National Cancer Institute (NCI) Strategic Partnering to Evaluate Cancer Signatures Grant No. U01 CA114722-01 (MJE), by the Sociedad Española de Oncología Médica (AP), by FEDER (RETICC-RD12/0036/0051, RD12/0036/0042, RD12/0036/0076, RD12/0036/0070), by Instituto de Salud Carlos III—PI13/01718 (AP), by Banco Bilbao Vizcaya Argentaria (BBVA) Foundation (AP) and by the Alliance Statistics and Data Center (U10-CA33601).
المصدر: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
BRITISH JOURNAL OF CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
British Journal of Cancerمصطلحات موضوعية: Oncology, Cancer Research, Análisis de supervivencia, Colorectal cancer, Triple Negative Breast Neoplasms, Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings], chemotherapy, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], Cohort Studies, Prostate cancer, 0302 clinical medicine, Clinical trials, Breast cancer, Quimioteràpia, Triple-negative breast cancer, Subtypes, 0303 health sciences, Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Survival Analysis [Medical Subject Headings], subtypes, Genomics, Middle Aged, 3. Good health, Treatment Outcome, Estudi de casos, 030220 oncology & carcinogenesis, Female, Neoadjuvant, Basal like, intrinsic, medicine.medical_specialty, Antineoplastic Agents, basal like, Càncer de mama, 03 medical and health sciences, breast cancer, Internal medicine, genomics, medicine, Humans, Chemotherapy, Lung cancer, Diseases::Neoplasms::Neoplasms by Site::Breast Neoplasms [Medical Subject Headings], Survival analysis, 030304 developmental biology, Proportional hazards model, business.industry, neoadjuvant, Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [Medical Subject Headings], Neoplasias de la mama triple negativas, Antineoplásicos, medicine.disease, Survival Analysis, Expressió gènica, Intrisic, Check Tags::Female [Medical Subject Headings], Intrinsic, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies [Medical Subject Headings], Clinical Study, Gene expression, Case studies, Resultado del tratamiento, Health Care::Health Services Administration::Quality of Health Care::Outcome and Process Assessment (Health Care)::Outcome Assessment (Health Care)::Treatment Outcome [Medical Subject Headings], Skin cancer, business, Assaigs clínics
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::688ea1cdfb20f095a971840b89349431Test
https://ddd.uab.cat/record/185079Test